| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging
|
Di Trapani, E.
|
|
|
39 |
7 |
p. 431.e15-431.e22
|
artikel
|
| 2 |
Artificial intelligence in urological oncology: An update and future applications
|
Brodie, Andrew
|
|
|
39 |
7 |
p. 379-399
|
artikel
|
| 3 |
Assessing quality of care in the diagnosis and treatment of early-stage testicular cancer: A critical review and summary
|
Huang, Mitchell M.
|
|
|
39 |
7 |
p. 400-408
|
artikel
|
| 4 |
Can repeat biopsy be skipped after initial complete resection of T1 bladder cancer? The role of a novel urinary mRNA biomarker
|
Elsawy, Amr A.
|
|
|
39 |
7 |
p. 437.e11-437.e19
|
artikel
|
| 5 |
Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors
|
Ma, Vincent T.
|
|
|
39 |
7 |
p. 437.e1-437.e9
|
artikel
|
| 6 |
Characterization of perioperative androgen profiles in men with bladder cancer undergoing radical cystectomy
|
Smelser, Woodson W.
|
|
|
39 |
7 |
p. 435.e23-435.e31
|
artikel
|
| 7 |
Clinical characteristics of renal cell carcinoma in patients under the age of 40
|
Douglas, Brian
|
|
|
39 |
7 |
p. 438.e23-438.e30
|
artikel
|
| 8 |
Clinicopathological significance and prognostic value of cancer-associated fibroblasts in prostate cancer patients
|
Wu, Zhenyu
|
|
|
39 |
7 |
p. 433.e17-433.e23
|
artikel
|
| 9 |
Cover 2 - Masthead
|
|
|
|
39 |
7 |
p. IFC
|
artikel
|
| 10 |
COVID-19 vaccination: Prioritization of at risk groups
|
Lundon, Dara J.
|
|
|
39 |
7 |
p. 375-378
|
artikel
|
| 11 |
Current practice patterns of society of urologic oncology members in performing inguinal lymph node staging/therapy for penile cancer: A survey study
|
Marilin, Nicholson
|
|
|
39 |
7 |
p. 439.e9-439.e15
|
artikel
|
| 12 |
Defining oligometastatic hormone sensitive prostate cancer and clinically significant outcomes: Implications on clinical trials?
|
Herrera-Caceres, Jaime O.
|
|
|
39 |
7 |
p. 431.e1-431.e8
|
artikel
|
| 13 |
Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma
|
Kardoust Parizi, Mehdi
|
|
|
39 |
7 |
p. 409-421
|
artikel
|
| 14 |
Financial incentives and wearable activity monitors to increase ambulation after cystectomy: A randomized controlled trial
|
Strother, Marshall
|
|
|
39 |
7 |
p. 434.e31-434.e38
|
artikel
|
| 15 |
Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma
|
Paciotti, Marco
|
|
|
39 |
7 |
p. 436.e1-436.e10
|
artikel
|
| 16 |
Implementation of a nonopioid protocol following robot-assisted radical cystectomy with intracorporeal urinary diversion
|
Pfail, John L.
|
|
|
39 |
7 |
p. 436.e9-436.e16
|
artikel
|
| 17 |
Is pelvic MRI imaging sufficient cross-sectional imaging for staging intermediate and high-risk prostate cancer?
|
Grant Owens, R.
|
|
|
39 |
7 |
p. 433.e9-433.e15
|
artikel
|
| 18 |
Leibovich score is the optimal clinico-pathological system associated with recurrence of non-metastatic clear cell renal cell carcinoma
|
Blackmur, James P.
|
|
|
39 |
7 |
p. 438.e11-438.e21
|
artikel
|
| 19 |
Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia
|
Jacewicz, Maciej
|
|
|
39 |
7 |
p. 432.e1-432.e7
|
artikel
|
| 20 |
Neoadjuvant chemotherapy in bladder cancer: Clinical benefit observed in prospective trials computed with restricted mean survival times
|
McCaw, Zachary R.
|
|
|
39 |
7 |
p. 435.e17-435.e22
|
artikel
|
| 21 |
Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer
|
Sung, Hyun Hwan
|
|
|
39 |
7 |
p. 434.e23-434.e29
|
artikel
|
| 22 |
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer?
|
Rico, Luis
|
|
|
39 |
7 |
p. 431.e9-431.e13
|
artikel
|
| 23 |
Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findings
|
Morote, Juan
|
|
|
39 |
7 |
p. 432.e11-432.e19
|
artikel
|
| 24 |
Screening for thromboembolic disease and select intervention in bulky advanced penile cancer
|
Hugar, Lee A
|
|
|
39 |
7 |
p. 373-374
|
artikel
|
| 25 |
STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer
|
Taber, Ann
|
|
|
39 |
7 |
p. 438.e1-438.e9
|
artikel
|
| 26 |
The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis
|
Packiam, Vignesh T.
|
|
|
39 |
7 |
p. 436.e1-436.e8
|
artikel
|
| 27 |
The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis
|
Hsieh, Po-Yen
|
|
|
39 |
7 |
p. 422-430
|
artikel
|
| 28 |
The role of multiparametric MRI in active surveillance for low-risk prostate cancer: The ROMAS randomized controlled trial
|
Schiavina, Riccardo
|
|
|
39 |
7 |
p. 433.e1-433.e7
|
artikel
|
| 29 |
Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer
|
Liu, Yu
|
|
|
39 |
7 |
p. 432.e1-432.e10
|
artikel
|
| 30 |
Tumor size and genomic risk in localized prostate cancer
|
Gaffney, Christopher
|
|
|
39 |
7 |
p. 434.e17-434.e22
|
artikel
|
| 31 |
Volume-outcome relationships for kidney cancer may be driven by disparities and patient risk
|
Wainger, Julia J.
|
|
|
39 |
7 |
p. 439.e1-439.e8
|
artikel
|
Tijdschrift beschrijving